Drug class · Infectious disease
Vaccines
Products in the FDA's vaccine class. Vaccines are usually reported with a CPT vaccine product code plus an immunization administration code, not with a J-code.
FDA-listed products
| Product | Strength | Form · route | Labeler | Product NDC |
|---|---|---|---|---|
| Virexasclepias tuberosa, echinacea purpurea, trifolium pratense, natrum muriaticum, phytolacca decandra, euphrasia officinalis, lac vaccinum (nspc), thuja occidentalis, calcarea arsenicica, camphora, influenzinum, cytomegalovirus nosode, morbillinum, variolinum, coxsackie a2 nosode, coxsackie a3 nosode, coxsackie a4 nosode, coxsackie a7 nosode, coxsackie b1 nosode, coxsackie b3 nosode, coxsackie b5 nosode, coxsackie a5 nosode, adenoviren nosode, epstein barr virus nosode, coxsackie b4 nosode | Asclepias tuberosa root 3 [hp_X]/mL + 25 more ingredients | SprayOral | Nutritional Specialties, Inc. | 83027-0050 |
| Virexadenoviren nosode, asclepias tuberosa, calcarea arsenicica, camphora, coxsackie a2 nosode, coxsackie a3 nosode, coxsackie a4 nosode, coxsackie a5 nosode, coxsackie a7 nosode, coxsackie b1 nosode, coxsackie b3 nosode, coxsackie b4 nosode, coxsackie b5 nosode, cytomegalovirus nosode, echinacea purpurea, epstein-barr virus nosode, euphrasia officinalis, influenzinum, lac vaccinum, morbillinum, natrum muriaticum, phytolacca decandra, thuja occidentalis, trifolium pratense, variolinum | Asclepias tuberosa root 3 [hp_X]/mL + 25 more ingredients | SprayOral | Nutritional Specialties, Inc. | 83027-0156 |
| Virus Nosode 4003virus nosode | Bacillus calmette-guerin live antigen, Unspecified substrain 30 [hp_X]/59mL + 9 more ingredients | LiquidOral | Professional Complementary Health Formulas | 63083-4003 |
| Vivotifsalmonella typhi ty21a | Salmonella typhi ty21a live antigen 6000000000 [CFU]/1 | Capsule, CoatedOral | Bavarian Nordic A/S | 50632-016 |
| Yf-Vaxyellow fever virus strain 17d-204 live antigen | Yellow fever virus strain 17d-204 live antigen 4.74 [PFU]/.5mL | Injection, Powder, Lyophilized, For suspensionSubcutaneous | Sanofi Vaccines US Inc. | 49281-915 |